DrugPatentWatch Database Preview
Patent: 10,182,984
» See Plans and Pricing
Summary for Patent: 10,182,984
| Title: | Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| Abstract: | Novel chimeric moieties that show significant efficacy against cancers are provided. In certain embodiments the chimeric moieties comprise a targeting moiety attached to an interferon. In certain embodiments, the chimeric moieties comprise fusion proteins where an antibody that specifically binds to a cancer marker is fused to interferon alpha (IFN-.alpha.) or interferon beta (IFN-.beta.). |
| Inventor(s): | Morrison; Sherie L. (Los Angeles, CA), Huang; Tzu-Hsuan (Libertyville, IL), Xuan; Caiyun (Newton, MA) |
| Assignee: | The Regents of the University of California (Oakland, CA) |
| Application Number: | 15/359,456 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,182,984
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 001 | 1997-11-26 | Start Trial | The Regents of the University of California (Oakland, CA) | 2027-09-21 | RX | search | |
| Genentech | RITUXAN | rituximab | SOLUTION;INTRAVENOUS | 103705 | 002 | 1997-11-26 | Start Trial | The Regents of the University of California (Oakland, CA) | 2027-09-21 | RX | search | |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 001 | 2017-06-22 | Start Trial | The Regents of the University of California (Oakland, CA) | 2027-09-21 | RX | Orphan | search |
| Genentech Inc | RITUXAN HYCELA | rituximab; hyaluronidase (human recombinant) | SOLUTION;SUBCUTANEOUS | 761064 | 002 | 2017-06-22 | Start Trial | The Regents of the University of California (Oakland, CA) | 2027-09-21 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,182,984
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Australia | 2008302111 | Start Trial |
| Brazil | PI0817108 | Start Trial |
| Canada | 2699944 | Start Trial |
| China | 101868246 | Start Trial |
| China | 103880965 | Start Trial |
| China | 108129573 | Start Trial |
| European Patent Office | 2200634 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
